How Industry Would Reduce The Regulatory Burden For Fleets Of Mobile Manufacturing Units

Stakeholders propose centralized oversight approaches for managing quality of “like-for-like” fleets of self-contained manufacturing units that could roam the US – or the world. The US FDA shares the industry’s thinking on how best to adapt the site-focused regulatory scheme it enforces to the emerging variety of distributed manufacturing systems.

Bloodmobile
one idea: draw from mobile blood collection regulatory approaches • Source: Shutterstock

More from Platform Technologies

More from Advanced Technologies